Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

1 terminated out of 32 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results89% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (6)
P 1 (2)
P 2 (3)
P 3 (3)

Trial Status

Unknown11
Completed8
Recruiting8
Not Yet Recruiting2
Active Not Recruiting1
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT04974671Phase 2Recruiting

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

NCT04525833Recruiting

Liver Disease and Other Systemic Diseases

NCT06867575Not ApplicableCompleted

Effects of Progressive Relaxation Exercises

NCT05983003Completed

Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

NCT06751251Active Not Recruiting

The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination

NCT05153330Phase 1Terminated

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

NCT07008716Phase 3Recruiting

Omitting CTV for Primary Tumor in LS-SCLC

NCT05791630Not ApplicableRecruiting

The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)

NCT06472388Phase 2Recruiting

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

NCT06409416Not Yet Recruiting

Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer

NCT04682457Completed

Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.

NCT05942456Recruiting

Soluble B7-H3 as a Biomarker for Osteosarcoma

NCT01651078Completed

Laser Ablation After Stereotactic Radiosurgery

NCT06235853Completed

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

NCT06174324Unknown

Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation

NCT05679986Unknown

Early Neurological Deterioration in Recent Small Subcortical Infarction

NCT04844437Unknown

Intrapartum Translabial Ultrasonography Reliability

NCT02761070Phase 3Unknown

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III

NCT05361772Not ApplicableUnknown

Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial

NCT05184829Not ApplicableNot Yet RecruitingPrimary

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

Scroll to load more

Research Network

Activity Timeline